CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −40 | $506.68 | $20K | 27,657 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −320 | $508.24 | $163K | 27,337 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −151 | $510.36 | $77K | 27,186 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −610 | $511.40 | $312K | 26,576 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −439 | $512.50 | $225K | 26,137 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −40 | $512.97 | $21K | 26,097 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −343 | $514.67 | $177K | 25,754 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −657 | $515.92 | $339K | 25,097 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −723 | $516.87 | $374K | 24,374 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −1,497 | $517.59 | $775K | 22,877 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −782 | $518.76 | $406K | 22,095 |
| 2026-05-22 | Levy Richard S Director | Sale 10b5-1 | −80 | $519.98 | $42K | 22,015 |
| 2026-05-18 | Soergel David Chief Medical Officer | Sale | −844 | $515.90 | $435K | 11,075 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −646 | $431.94 | $279K | 13,826 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −40 | $425.08 | $17K | 13,786 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −420 | $426.86 | $179K | 13,366 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −80 | $427.85 | $34K | 13,286 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −160 | $429.00 | $69K | 13,126 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −40 | $429.58 | $17K | 13,086 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −120 | $430.90 | $52K | 12,966 |
Page 4 of 82 · 1,629 trades